Elevance Health, Inc. — Form 10-Q
Filed October 21, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
CEO Gail K. Boudreaux and CFO Mark B. Kaye certified on October 21, 2026 that the Q3 2026 10-Q filing complies with SEC requirements, financial statements fairly present the company's condition and results, and internal controls over financial reporting are designed and operating effectively. No material weaknesses, deficiencies, or fraud involving management were disclosed.
Why this rating
Routine SOX 302/906 certifications; boilerplate quarterly filing requirement with no disclosed control issues or changes.
See more from October 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.